Want updates from this article collection?
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign UpViral infections.
• shared collection1 papers • 0 to 25 followers • Breaking studies about viruses and their treatment.
By Mohamed Elmustafa Elsayed • Infectious diseases and medical microbiology trainee, severn infection sciences. Member of the royal college of physicians, London. Member of the british infection association, member of the healthcare infection society, member of the european society of clinical microbiology and infectious diseases.
#1
Christine M Durand, Mary G Bowring, Diane M Brown, Michael A Chattergoon, Guido Massaccesi, Nichole Bair, Russell Wesson, Ashraf Reyad, Fizza F Naqvi, Darin Ostrander, Jeremy Sugarman, Dorry L Segev, Mark Sulkowski, Niraj M Desai
Background: Given the high mortality rate for patients with end-stage kidney disease receiving dialysis and the efficacy and safety of hepatitis C virus (HCV) treatments, discarded kidneys from HCV-infected donors may be a neglected public health resource. Objective: To determine the tolerability and feasibility of using direct-acting antivirals (DAAs) as prophylaxis before and after kidney transplantation from HCV-infected donors to non-HCV-infected recipients (that is, HCV D+/R- transplantation)...
April 17, 2018: Annals of Internal Medicine
1
Fetching more papers... 
